Going by the proactive interview with JC he suggests if things go well with this type of vaccine tech the product to market time is reduced, 2020 being the target.
Professor Frazer has already put many years into this.. And I'm guessing this has come out of some his earlier work on EBV.
Going by the proactive interview with JC he suggests if things...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.50 |
Change
-0.050(0.27%) |
Mkt cap ! $363.6M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.50 | $79.49K | 4.247K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 130 | $18.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.89 | 345 | 1 |
View Market Depth
| Last trade - 13.48pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |